Written by: Douglas W. Crandell, Ph.D. and Eric Furman, Ph.D. Drug development programs face unique challenges in demonstrating the safety and... Read More

Written by: Alistair J. McIntyre and Agnes Juang, Ph.D. On March 17, 2025, a bipartisan group of senators introduced two bills... Read More

Written by: Susan M. Janicki, Ph.D. and Joseph Mallon, Ph.D. On March 6, 2025, the National Institutes of Health (NIH) announced... Read More

Written by: Rhett D. Ramsey and Robert J. Hilton, Ph.D. Congress authorized the FDA to determine whether a drug is “in... Read More

Written by: Bailey R. Arenberg and Jason J. Jardine Effective January 28, 2025, the new administration suspended the Climate Change Mitigation... Read More

Written by:Bailey R. Arenberg & Jason J. Jardine With the recent convocation of the 119th Congress, a change in administration,... Read More